Atul Kabra

1.5k total citations
70 papers, 886 citations indexed

About

Atul Kabra is a scholar working on Molecular Biology, Complementary and alternative medicine and Plant Science. According to data from OpenAlex, Atul Kabra has authored 70 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Complementary and alternative medicine and 14 papers in Plant Science. Recurrent topics in Atul Kabra's work include Phytochemicals and Antioxidant Activities (12 papers), Medicinal Plants and Neuroprotection (10 papers) and Essential Oils and Antimicrobial Activity (9 papers). Atul Kabra is often cited by papers focused on Phytochemicals and Antioxidant Activities (12 papers), Medicinal Plants and Neuroprotection (10 papers) and Essential Oils and Antimicrobial Activity (9 papers). Atul Kabra collaborates with scholars based in India, Saudi Arabia and Pakistan. Atul Kabra's co-authors include Rohit Sharma, PK Prajapati, Natália Martins, Uttam Singh Baghel, Christophe Hano, Kamil Kuča, Duangjai Tungmunnithum, Samantha Drouet, Manish Kumar and Ashun Chaudhary and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecules.

In The Last Decade

Atul Kabra

67 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atul Kabra India 18 218 200 188 138 125 70 886
Ayodeji B. Oyenihi South Africa 15 117 0.5× 193 1.0× 161 0.9× 118 0.9× 125 1.0× 29 773
Nahida Tabassum India 17 209 1.0× 258 1.3× 230 1.2× 80 0.6× 156 1.2× 42 958
Ghulam Abbas Pakistan 20 173 0.8× 265 1.3× 246 1.3× 98 0.7× 108 0.9× 74 1.1k
Asie Shojaii Iran 15 175 0.8× 224 1.1× 145 0.8× 80 0.6× 140 1.1× 45 671
Leticia Garduño‐Siciliano Mexico 17 119 0.5× 179 0.9× 227 1.2× 126 0.9× 177 1.4× 45 805
Mani Iyer Prasanth Thailand 19 255 1.2× 140 0.7× 306 1.6× 146 1.1× 129 1.0× 51 1.2k
Rosa Direito Portugal 19 133 0.6× 169 0.8× 246 1.3× 173 1.3× 193 1.5× 48 936
Wendy Weissner United States 17 246 1.1× 225 1.1× 167 0.9× 104 0.8× 122 1.0× 38 909
Sakshi Painuli India 16 126 0.6× 271 1.4× 304 1.6× 127 0.9× 179 1.4× 34 850
Gireesh Kumar Singh India 16 226 1.0× 140 0.7× 245 1.3× 84 0.6× 102 0.8× 34 887

Countries citing papers authored by Atul Kabra

Since Specialization
Citations

This map shows the geographic impact of Atul Kabra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul Kabra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul Kabra more than expected).

Fields of papers citing papers by Atul Kabra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atul Kabra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul Kabra. The network helps show where Atul Kabra may publish in the future.

Co-authorship network of co-authors of Atul Kabra

This figure shows the co-authorship network connecting the top 25 collaborators of Atul Kabra. A scholar is included among the top collaborators of Atul Kabra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atul Kabra. Atul Kabra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albekairi, Norah A., et al.. (2025). Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis. Scientific Reports. 15(1). 767–767. 1 indexed citations
2.
Kabra, Atul, et al.. (2025). Exploring myricetin: A comprehensive review of its pharmacological potential, formulation strategies, and clinical outlook. Naunyn-Schmiedeberg s Archives of Pharmacology. 399(3). 3189–3225.
4.
Kabra, Atul, Wendy B. Katzman, Nancy E. Lane, & Lora Giangregorio. (2025). OsteoStrong and bone health: a scoping review. Osteoporosis International. 36(9). 1521–1534. 1 indexed citations
6.
Er-rajy, Mohammed, Burak Tüzün, Asmae Nakkabi, et al.. (2024). Design, synthesis, characterization, and theoretical calculations, along with in silico and in vitro antimicrobial proprieties of new isoxazole-amide conjugates. Open Chemistry. 22(1). 8 indexed citations
7.
Pandey, Sadanand, et al.. (2024). The futuristic applications of transition metal dichalcogenides for cancer therapy. Luminescence. 39(5). e4771–e4771. 3 indexed citations
8.
Pathak, Rashmi, Neetu Sachan, Atul Kabra, et al.. (2023). Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy. Saudi Pharmaceutical Journal. 31(8). 101687–101687. 5 indexed citations
9.
Shahzad, Saleem, Shabana Bibi, Qudsia Yousafi, et al.. (2022). Identification of Effective and Nonpromiscuous Antidiabetic Drug Molecules from Penicillium Species. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 4 indexed citations
10.
Kumar, Manish, et al.. (2022). Caffeic Acid Prevents Vascular Oxidative Stress and Atherosclerosis against Atherosclerogenic Diet in Rats. Evidence-based Complementary and Alternative Medicine. 2022. 1–8. 27 indexed citations
11.
Singab, Abdel Nasser B., et al.. (2022). Herbal Arsenal against Skin Ailments: A Review Supported by In Silico Molecular Docking Studies. Molecules. 27(19). 6207–6207. 3 indexed citations
12.
Arora, Vimal, et al.. (2022). Magnetosomes: A Tool for Targeted Drug Delivery in the Management of Cancer. Journal of Nanomaterials. 2022(1). 8 indexed citations
13.
Bibi, Shabana, Hitesh Chopra, Muhammad Saad Khan, et al.. (2022). In Silico and In Vitro Screening Constituents of Eclipta alba Leaf Extract to Reveal Antimicrobial Potential. Evidence-based Complementary and Alternative Medicine. 2022. 1–14. 7 indexed citations
14.
Yousafi, Qudsia, Shabana Bibi, Saleem Shahzad, et al.. (2022). Identification of Novel and Safe Fungicidal Molecules against Fusarium oxysporum from Plant Essential Oils: In Vitro and Computational Approaches. BioMed Research International. 2022(1). 5347224–5347224. 5 indexed citations
15.
Liu, Zhiyong, Manish Kumar, & Atul Kabra. (2022). Cucurbitacin B exerts neuroprotection in a murine Alzheimer’s disease model by modulating oxidative stress, inflammation, and neurotransmitter levels. Frontiers in Bioscience-Landmark. 27(2). 71–71. 19 indexed citations
16.
Ayaz, Muhammad, Sajjad Ahmad, Abdul Sadiq, et al.. (2022). Underlying Anticancer Mechanisms and Synergistic Combinations of Phytochemicals with Cancer Chemotherapeutics: Potential Benefits and Risks. Journal of Food Quality. 2022. 1–15. 32 indexed citations
17.
Singh, Thakur Gurjeet, et al.. (2022). Cardioprotection by Citrus grandis (L.) Peel Ethanolic Extract in Alloxan‐Induced Cardiotoxicity in Diabetic Rats. BioMed Research International. 2022(1). 2807337–2807337. 3 indexed citations
18.
Kabra, Atul, et al.. (2021). Alzheimer Disease –Etiology, Pathophysiology and Treatment: An Overview. Annals of the Romanian Society for Cell Biology. 3548–3556. 4 indexed citations
19.
Kabra, Atul, et al.. (2020). Global Pandemic Conditions and List of Possible Medications and Vaccines for the Treatment of COVID-19: A Review. SHILAP Revista de lepidopterología. 3(Special-1). 90–102. 2 indexed citations
20.
Kabra, Atul, et al.. (2015). Plant Species used by locals as Ethano - Medicine in Gohar Tehsil, Distt. Mandi Region of North Western Himalaya. Pharmatutor. 3(4). 47–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026